Seeking Alpha

Savient Pharmaceuticals (SVNT -6%) dips after JMP Securities cuts the shares to Market...

Savient Pharmaceuticals (SVNT -6%) dips after JMP Securities cuts the shares to Market Underperform, citing limited growth potential for the company's gout treatment drug Krystexxa.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|